BR112012031440A2 - derivados trissacarídeo e seu uso como adjuvantes - Google Patents

derivados trissacarídeo e seu uso como adjuvantes

Info

Publication number
BR112012031440A2
BR112012031440A2 BR112012031440A BR112012031440A BR112012031440A2 BR 112012031440 A2 BR112012031440 A2 BR 112012031440A2 BR 112012031440 A BR112012031440 A BR 112012031440A BR 112012031440 A BR112012031440 A BR 112012031440A BR 112012031440 A2 BR112012031440 A2 BR 112012031440A2
Authority
BR
Brazil
Prior art keywords
adjuvants
trisaccharide derivatives
trisaccharide
derivatives
Prior art date
Application number
BR112012031440A
Other languages
English (en)
Portuguese (pt)
Inventor
Joannes Peter Maria Schenkelaars Everardus
Anne Turkstra Jouwert
Gernardus Mathias Marie Van Bree Johannes
Aldegonda Jacoba Kriek Maria
Patrick Hof Robert
Martinus Maria Schaaper Wilhelmus
Original Assignee
Immunovo B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovo B V filed Critical Immunovo B V
Publication of BR112012031440A2 publication Critical patent/BR112012031440A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06Fatty acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
BR112012031440A 2010-06-11 2011-06-03 derivados trissacarídeo e seu uso como adjuvantes BR112012031440A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10165707A EP2397484A1 (en) 2010-06-11 2010-06-11 Trisaccharide derivates, and their use as adjuvants
PCT/NL2011/050393 WO2011155822A1 (en) 2010-06-11 2011-06-03 Trisaccharide derivates, and their use as adjuvants

Publications (1)

Publication Number Publication Date
BR112012031440A2 true BR112012031440A2 (pt) 2017-04-18

Family

ID=43734127

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012031440A BR112012031440A2 (pt) 2010-06-11 2011-06-03 derivados trissacarídeo e seu uso como adjuvantes

Country Status (25)

Country Link
US (2) US9327020B2 (https=)
EP (3) EP2397484A1 (https=)
JP (2) JP6004586B2 (https=)
KR (1) KR101929973B1 (https=)
CN (1) CN103154013B (https=)
AU (1) AU2011262606B2 (https=)
BR (1) BR112012031440A2 (https=)
CA (1) CA2802023C (https=)
CY (1) CY1119704T1 (https=)
DK (1) DK2580226T3 (https=)
ES (1) ES2654156T3 (https=)
HR (1) HRP20171947T1 (https=)
HU (1) HUE035187T2 (https=)
IL (1) IL223570A (https=)
LT (1) LT2580226T (https=)
MX (1) MX342946B (https=)
NO (1) NO2580226T3 (https=)
PL (1) PL2580226T3 (https=)
PT (1) PT2580226T (https=)
RS (1) RS56690B1 (https=)
RU (1) RU2595717C2 (https=)
SI (1) SI2580226T1 (https=)
SM (1) SMT201700603T1 (https=)
WO (1) WO2011155822A1 (https=)
ZA (1) ZA201209395B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants
PL3193923T3 (pl) 2014-07-24 2020-03-31 Litevax B.V. Adiuwanty
KR102922337B1 (ko) 2023-10-11 2026-02-05 세종대학교산학협력단 삼당류의 제조방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232150A (en) * 1979-07-09 1980-11-04 American Cyanamid Company Oligosaccharide precursors to substituted O-α-D and O-β-D-multigalactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6α-D-glucopyranoses
GB8703128D0 (en) * 1987-02-11 1987-03-18 Donmarn Ltd Anti-scaling compounds
US5543505A (en) * 1993-03-15 1996-08-06 Sloan-Kettering Institute For Cancer Research Synthetic compounds which bind to H. pylori, and uses thereof
US6303120B1 (en) * 1994-03-15 2001-10-16 Memorial Sloan-Kettering Institute For Cancer Research Synthesis of glycoconjugates of the lewis y epitope and uses thereof
US5708163A (en) * 1994-03-15 1998-01-13 Sloan-Kettering Institute Of Cancer Research Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof
ES2208687T3 (es) * 1994-08-04 2004-06-16 Elan Drug Delivery Limited Sistema de administracion de sustancias solidas para la liberacion controlada de moleculas incorporadas en tales sustancias y procedimientos para la fabricacion de tales sistemas.
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US6517860B1 (en) * 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
JP3041799B1 (ja) * 1998-09-29 2000-05-15 株式会社微生物化学研究所 新規なアジュバント及びそれを用いたワクチン
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
GB0124710D0 (en) * 2001-10-15 2001-12-05 Quadrant Healthcare Uk Ltd Therapeutic composition
DE602005010101D1 (de) * 2005-12-01 2008-11-13 Wella Ag Verwendung von Di- oder Oligosaccharidepolyestern in Haarstylingprodukten
US9045516B2 (en) * 2007-04-16 2015-06-02 Suri Saranathan Iyer Synthetic ligands for the differentiation of closely related toxins and pathogens
WO2009140683A1 (en) * 2008-05-16 2009-11-19 Research Foundation Of The City University Of New York Living copolymer protein/peptide hybrids for biomedical applications
CA2750188C (en) * 2009-02-02 2016-11-29 Otsuka Chemical Co., Ltd. Low-molecular polysulfated hyaluronic acid derivative and compositions containing same
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants

Also Published As

Publication number Publication date
RU2595717C2 (ru) 2016-08-27
PL2580226T3 (pl) 2018-05-30
MX2012014422A (es) 2013-08-27
AU2011262606A1 (en) 2013-01-10
LT2580226T (lt) 2018-02-26
EP2397484A1 (en) 2011-12-21
SI2580226T1 (en) 2018-04-30
EP2580226A1 (en) 2013-04-17
US20170057987A1 (en) 2017-03-02
ZA201209395B (en) 2014-05-28
KR101929973B1 (ko) 2018-12-18
HRP20171947T1 (hr) 2018-02-23
SMT201700603T1 (it) 2018-03-08
CY1119704T1 (el) 2018-06-27
CN103154013B (zh) 2017-03-15
CA2802023C (en) 2020-07-14
JP2013528211A (ja) 2013-07-08
MX342946B (es) 2016-10-18
US20130273082A1 (en) 2013-10-17
EP3312188A1 (en) 2018-04-25
PT2580226T (pt) 2018-01-05
AU2011262606B2 (en) 2016-10-27
US9327020B2 (en) 2016-05-03
RU2013100945A (ru) 2014-07-20
RS56690B1 (sr) 2018-03-30
NO2580226T3 (https=) 2018-04-28
IL223570A (en) 2017-03-30
ES2654156T3 (es) 2018-02-12
CA2802023A1 (en) 2011-12-15
EP2580226B1 (en) 2017-11-29
DK2580226T3 (en) 2018-01-08
CN103154013A (zh) 2013-06-12
KR20130056273A (ko) 2013-05-29
JP2016216471A (ja) 2016-12-22
HUE035187T2 (hu) 2018-05-02
WO2011155822A1 (en) 2011-12-15
JP6004586B2 (ja) 2016-10-12

Similar Documents

Publication Publication Date Title
CY2021021I1 (el) Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες και η χρηση τους
BR112013012190A2 (pt) composições adesivas e seus usos
BR112013014725A2 (pt) derivados estrigolactamasestrigolactama e seu uso como reguladores plantas
BRPI1010533A2 (pt) tetrahidroazolopirazinas sulfoniladas e seu uso como medicamentos
BR112013014314A2 (pt) derivados de 6-amino-2-fenilamino-1h-benzimidazol-5-carboxamida e seu uso como inibidores de prostaglandina e2 sintase-1 microssômicas
PT3109248T (pt) Derivados de heteroarilpiperidina e piperazina como fungicidas
BR112013016030A2 (pt) compostos e seu uso como inibidores de bace
DK2648809T3 (da) Naturlige formuleringer
DK2366310T3 (da) Siddemøbel
HUE037355T2 (hu) Nedvszívó szerkezet
BR112013012129A2 (pt) composições de adesivos e seus usos
BRPI1008082A2 (pt) Isotiazoliloxifenilamisinas e seu emprego como fungicidas
BRPI0913885A2 (pt) Tiadiazoliloxifenilamidinas e seus uso como fungicidas
BR112013010988A2 (pt) composição fluída e uso
BR112012008044A2 (pt) pteridinas e seu uso como agroquímicos
IT1403847B1 (it) Composizioni farmaceutiche comprendenti rifaximina e loro uso.
DK2437634T3 (da) Siddemøbel
BR112013015378A2 (pt) misturador dinâmico e seu uso
BR112014005406A2 (pt) composição de vacina e respectivo uso
CO6781486A2 (es) Compuestos y su uso
BR112013008898A2 (pt) benzamidas substituídas e seus usos
BR112013033919A2 (pt) combinações e seus usos
DK2938186T3 (da) Organ- og vævsbevaringsformuleringer med øget stabilitet og holdbarhed
BR112013013551A2 (pt) composto e uso médico do mesmo
BRPI0920502A2 (pt) compostos cicloundecadepsipeptídeos e seu uso como medicamento

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements